Hydrochloric Acid → HCID 9826810, compound
Reaction equation
O1CCCCC1[O:7][NH:8][C:9](=[O:37])[CH2:10][C:11]1([C:24]2[S:25][C:26]([C:29]3[CH:34]=[CH:33][C:32]([O:35][CH3:36])=[CH:31][CH:30]=3)=[CH:27][CH:28]=2)[S:17](=[O:19])(=[O:18])[CH2:16][CH2:15][N:14]([S:20]([CH3:23])(=[O:22])=[O:21])[CH2:13][CH2:12]1.Cl>CO>[OH:7][NH:8][C:9](=[O:37])[CH2:10][C:11]1([C:24]2[S:25][C:26]([C:29]3[CH:34]=[CH:33][C:32]([O:35][CH3:36])=[CH:31][CH:30]=3)=[CH:27][CH:28]=2)[S:17](=[O:18])(=[O:19])[CH2:16][CH2:15][N:14]([S:20]([CH3:23])(=[O:22])=[O:21])[CH2:13][CH2:12]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of N-(2-tetrahydropyranyloxy)-2-[7-(5-(4-methoxyphenyl)-2-thienyl)-4-methanesulfonyl-1,1-dioxoperhydro-1,4-thiazepin-7-yl]acetamide (110 mg) in methanol (2 ml) was added 10% hydrogen chloride in methanol (0.5 ml) at room temperature. After being stirred for 30 minutes, the reaction mixture was concentrated in vacuo. The resulting residue was purified by silica gel column chromatography (eluent; 0.5-5% methanol in chloroform) to give N-hydroxy-2-[7-(5-(4-methoxyphenyl)-2-thienyl)-4-methanesulfonyl-1,1-dioxoperhydro-1,4-thiazepin-7-yl]acetamide (50 mg) as an amorphous powder.
Workup
- concentrationthe reaction mixture was concentrated in vacuo
- customThe resulting residue was purified by silica gel column chromatography (eluent; 0.5-5% methanol in chloroform)
Sources & evidence
- ORD record
- ord-22ef6cb27ed54154911d551a425fc19a
- Source dataset
- uspto-grants-2005_11
- Patent number
- US06967197B2
Reaction notes
Loading…